A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease

Nature Structural Biology

Volumn 10, Issue 2, 2003, Pages 136-140

  Kallenberger, Bettina C ^a,b   Love, James D ^a   Chatterjee, V Krishna K ^b   Schwabe, John W R ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR;

ANISOTROPY; ARTICLE; CARBOXY TERMINAL SEQUENCE; DIABETES MELLITUS; FLUORESCENCE ANALYSIS; GENE EXPRESSION; INSULIN RESISTANCE; LIGAND BINDING; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTOR BINDING; REGULATORY MECHANISM;

BINDING SITES; DIABETES MELLITUS, TYPE 2; FLUORESCENCE POLARIZATION; HUMANS; INSULIN RESISTANCE; LIGANDS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS;

EID: 0037317303     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb892     Document Type: Article

References (33)

1. Darimont, B.D. et al. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356 (1998).
2. Shiau, A.K. et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927-937 (1998).
3. Nolte, R. et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor. Nature 395, 137-143 (1998).
4. Bourguet, W., Ruff, M., Chambon, R., Gronemeyer, H., & Moras, D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375, 377-382 (1995).
5. Brzozowski, A.M. et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758 (1997).
6. Pike, A.C. et al. Structure of the ligand-binding domain of oestrogen receptor βε in the presence of a partial agonist and a full antagonist. EMBO J. 18, 4608-4618 (1999).
7. Gampe, R.T. Jr. et al. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev. 14, 2229-2241 (2000).
8. Bourguet, W. et al. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5, 289-298 (2000).
9. Pike, A.C. et al. Structural insights into the mode of action of a pure antiestrogen. Structure 9, 145-153 (2001).
10. Watkins, R.E. et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292, 2329-2333 (2001).
11. Clayton, G.M., Peak-Chew, S.Y., Evans, R.M., & Schwabe, J.W. The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation. Proc. Natl. Acad. Sci. USA 98, 1549-1554 (2001).
12. Xu, H.E. et al. Structural basis for antagonist-mediated recruitment of nuclear corepressors by PPARα. Nature 415, 813-817 (2002).
13. Hu, X., & Lazar, M.A. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402, 93-96 (1999).
14. Perissi, V. et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13, 3198-3208 (1999).
15. Nagy, L. et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev. 13, 3209-3216 (1999).
16. Webb, P. et al. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14, 1976-1985 (2000).
17. Barroso, I. et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883 (1999).
18. Chong, S. et al. Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element. Gene 192, 271-281 (1997).
19. Lehmann, J.M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956 (1995).
20. Yguerabide, J., Epstein, H.F., & Stryer, L. Segmental flexibility in an antibody molecule. J. Mol. Biol. 51, 573-590 (1970).
21. Verganl, B. et al. Backbone dynamics of Tet repressor α8-α9 loop. Biochemistry 39, 2759-2768 (2000).
22. Gangal, M. et al. Backbone flexibility of five sites on the catalytic subunit of cAMP-dependent protein kinase in the open and closed conformations. Biochemistry 37, 13728-13735 (1998).
23. Mielke, T., Alexiev, U., Glasel, M., Otto, H., & Heyn, M.P. Light-induced changes in the structure and accessibility of the cytoplasmic loops of rhodopsin in the activated MII state. Biochemistry 41, 7875-7884 (2002).
24. 1H NMR spectroscopy. Biochemistry 29, 7387-7401 (1990).
25. Johnson, B.A. et al. Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activation. J. Mol. Biol. 298, 187-194 (2000).
26. Cronet, P. et al. Structure of the PPARα and -γ ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family. Structure 9, 699-706 (2001).
27. Gangloff, M. et al. Crystal structure of a mutant hERα ligand-binding domain reveals key structural features for the mechanism of partial agonism. J. Biol. Chem. 276, 15059-15065 (2001).
28. Schulman, I.G., Juguilon, H., & Evans, R.M. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16, 3807-3813 (1996).
29. Tanenbaum, D.M., Wang, Y., Williams, S.R & Sigler, P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA 95, 5998-6003 (1998).
30. Love, J.D. et al. The structural basis for the specificity of retinoid-X-receptor selective agonists: new insights into the role of helix H12. J. Biol. Chem. 277, 11385-11391 (2002).
31. Gregory, C., Hayes, M., Jones, G., & Pantos, E. FLUOR - a program to analyse fluorescence data. in Daresbury Laboratory Technical Memorandum (Daresbury Laboratory, Warrington; 1994).
32. Brown, K.K. et al. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes 48, 1415-1424 (1999).
33. Li, F. et al. Evidence for an internal entropy contribution to phosphoryl transfer: a study of domain closure, backbone flexibility, and the catalytic cycle of cAMP-dependent protein kinase. J. Mol. Biol. 315, 459-469 (2002).